CASP3 and malignant colon neoplasm: We have now found that IL-17-mediated resistance to the caspase-3 activation that is induced by 5-FU was effectively abolished by copper chelation with TTM or by addition of XIAP inhibitor in patient-derived colon cancer organoids (Fig. 6g, h).